Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2269 stock hub

HKG/2269 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2269is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

135.1B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2269

In the news

Latest news · HKG/2269

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.8

P25 11.7P50 18.9P75 41.4

Trailing P/E25.3

P25 10.7P50 17.9P75 38.5

ROE11.6

P25 -14.7P50 2P75 9.4

ROIC13

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2269 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

CNY

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	13,252
Employees Change	677%
Employees Change Percent	5.38
Enterprise value	HKD 127.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG970081173
Last refreshed	2026-05-10
Market cap	HKD 135.1B
Price	HKD 32.66
Price currency	HKD
Rev Per Employee	1,829,773.27x
Sector	Healthcare
Sic	8731
Symbol	hkg/2269
Website	https://www.wuxibiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.04%
EV Earnings	23.35x
EV/EBIT	17.24x
EV/EBITDA	14.16x
EV/FCF	43.15x
EV/Sales	5.26x
FCF yield	2.19%
Forward P/E	19.76x
P/B ratio	2.29x
P/E ratio	25.29x
P/S ratio	5.57x
PE Ratio10 Y	56.58x
PE Ratio3 Y	24.87x
PE Ratio5 Y	26.57x
PEG ratio	1.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.5%
EBITDA Margin	36.37%
FCF margin	12.19%
Gross margin	45.98%
Gross Profit	HKD 11.1B
Gross Profit Growth	17.12%
Gross Profit Growth Q	34.06%
Gross Profit Growth3 Y	14.83%
Gross Profit Growth5 Y	7.83%
Net Income	HKD 5.5B
Net Income Growth	46.25%
Net Income Growth Q	38.35%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	23.09%
Net Income Growth5 Y	3.4%
Pretax Margin	33.3%
Profit Margin	22.53%
Profit Per Employee	HKD 412,168
Profitable Years	12
ROA	6.88
Roa5y	5.56
ROCE	12
ROE	11.64
Roe5y	11.13
ROIC	12.99
Roic5y	11.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	50.55%
Cagr3y	-11.7%
Cagr5y	-20.34%
EPS Growth	47.93
EPS Growth Q	39.41
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	24.61
EPS Growth5 Y	4.1
FCF Growth	106.25%
FCF Growth Q	48.39%
FCF Growth5 Y	15.92%
OCF Growth	21.54%
OCF Growth Q	15.81%
OCF Growth10 Y	12.92%
OCF Growth3 Y	25.35%
OCF Growth5 Y	-1.49%
Revenue Growth	16.68x
Revenue Growth Q	17.18x
Revenue Growth Quarters	23x
Revenue Growth Years	11x
Revenue Growth3 Y	8.38x
Revenue Growth5 Y	5.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.36
Assets	HKD 70.9B
Cash	HKD 17.5B
Current Assets	HKD 32.4B
Current Liabilities	HKD 9.6B
Debt	HKD 3.5B
Debt EBITDA	HKD 0.38
Debt Equity	HKD 0.06
Debt FCF	HKD 1.17
Equity	HKD 59B
Interest Coverage	46.46
Liabilities	HKD 11.9B
Long Term Assets	HKD 38.5B
Long Term Liabilities	HKD 2.3B
Net Cash	HKD 14.1B
Net Cash By Market Cap	HKD 10.4
Net Cash Growth	118.87%
Net Debt EBITDA	HKD -1.59
Net Debt Equity	HKD -0.24
Net Debt FCF	HKD -4.76
Tangible Book Value	HKD 50.4B
Tangible Book Value Per Share	HKD 12.18
WACC	7.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.39
Inventory Turnover	8.11
Net Working Capital	HKD 6B
Quick ratio	2.96
Working Capital	HKD 22.1B
Working Capital Turnover	HKD 1.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	50.51%
200-day SMA	35.02
3Y total return	-31.17%
50-day SMA	35.11
50-day SMA vs 200-day SMA	50over200
5Y total return	-67.92%
All Time High	148
All Time High Change	-77.93%
All Time High Date	2021-07-02
All Time Low	8.33
All Time Low Change	291.94%
All Time Low Date	2017-06-13
ATR	1.35
Beta	0.58
Beta1y	1.5
Beta2y	1
Ch YTD	3.88
High	32.98
High52	44
High52 Date	2026-02-12
High52ch	-25.77%
Low	32.16
Low52	21.8
Low52 Date	2025-05-12
Low52ch	49.82%
Ma50ch	-6.98%
Price vs 200-day SMA	-6.74%
RSI	40.83
RSI Monthly	50.77
RSI Weekly	44.91
Sharpe ratio	0.89x
Sortino ratio	1.52
Total Return	1.22%
Tr YTD	3.88
Tr1m	-6.63%
Tr1w	-5.5%
Tr3m	-13.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 7.4B
Operating Income Growth	21.06
Operating Income Growth Q	41.81
Operating Income Growth3 Y	24.43
Operating Income Growth5 Y	9.78
Operating margin	30.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,738,930,707%
Net Borrowing	-2,048,831,040.4
Shares Insiders	1.15%
Shares Institutions	37.35%
Shares Out	4,137,793,436
Shares Qo Q	-0.48%
Shares Yo Y	-1.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.9B
Average Volume	23,948,768x
Bv Per Share	12.72
CAPEX	HKD -4.1B
Ch1m	-6.63
Ch1w	-5.5
Ch1y	50.51
Ch3m	-13.32
Ch3y	-31.17
Ch5y	-67.92
Ch6m	-3.32
Change	-1.86%
Change From Open	-0.73
Close	33.28
Days Gap	-1.14
Depreciation Amortization	1,471,789,704.7
Dollar Volume	982,431,906.1
Earnings Date	2026-03-24
EBIT	HKD 7.4B
EBITDA	HKD 8.8B
EPS	HKD 1.29
F Score	8
FCF	HKD 3B
FCF EV Yield	2.32x
FCF Per Share	HKD 0.71
Financing CF	-2,408,085,767
Fiscal Year End	December
Founded	2,014
Goodwill	1,761,792,434.2
Graham Number	20.58307
Graham Upside	-36.98
Income Tax	HKD 1.7B
Investing CF	-3,435,403,255
Is Primary Listing	1
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Last Split Date	2020-11-16
Last Split Type	Forward
Lynch Fair Value	HKD 6.6
Lynch Upside	-79.79
Ma150	35.65
Ma150ch	-8.38%
Ma20	34.65
Ma20ch	-5.73%
Net CF	1,040,036,909
Open	32.9
P FCF Ratio	45.73
P OCF Ratio	19.15
Position In Range	60.98
Ppne	34,263,655,397.2
Price Date	2026-05-08
Price EBITDA	HKD 15.32
Ptbv Ratio	2.68
Relative Volume	1.29x
Revenue	24,248,155,335x
SBC By Revenue	4.38x
Share Based Comp	1,062,794,991
Tax By Revenue	6.99x
Tax Rate	21%
Tr6m	-3.32%
Volume	30,080,585
Z Score	7.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2269 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2269 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2269?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.4%

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.2%

Negative means the company is buying back shares.

Technical

HKG/2269 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.8

Neutral momentum band

Price vs 200-day MA

-6.7%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2269

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2269 stock rating?

hkg/2269 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2269 analysis?

The full report lives at /stocks/hkg/2269/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2269?

The latest report frames hkg/2269 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2269 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.